<DOC>
	<DOCNO>NCT02153671</DOCNO>
	<brief_summary>This study design ass whether live attenuate Influenza vaccine ( LAIV ) induce long-lasting immune memory compare immunologic response two dos OrniFlu® inactivate vaccine give subject previously prim LAIV subject receive LAIV .</brief_summary>
	<brief_title>Immunogenicity H5N1 Vaccine Following H5N2</brief_title>
	<detailed_description>This open-label study evaluate immunogenic activity OrniFlu® inactivate influenza vaccine give healthy adult volunteer participate double blind placebo-controlled study protocol LAIV H5N2-01 Institute Influenza September-October 2012 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Legal male female adult 18 51 year age enrollment visit Literate willing provide write informed consent A sign informed consent Free obvious health problem , establish medical history screening evaluation , include physical examination Capable willing complete memory aid willing return followup visit For female , willing take reliable birth control measure Day 56 Participation another clinical trial involve investigational agent within previous three month plan enrollment trial period study Receipt nonstudy vaccine within four week prior enrollment refusal postpone receipt Participation clinical trial involve H5matched influenza vaccine except Protocol LAIVH5N201 Current recent ( within two week enrollment ) acute respiratory illness without fever Other acute illness time study enrollment Receipt immunoglobulin blood product within three month prior study enrollment plan receipt study period Chronic administration ( define 14 consecutivelyprescribed day ) immunosuppressant and/or immunemodulating therapy within six month prior study enrollment History bronchial asthma Hypersensitivity previous administration ( influenza ) vaccine . Other AE follow immunization least possibly relate previous receipt ( influenza ) vaccine Suspected know hypersensitivity study vaccine component , include protein chicken eggs Seasonal ( autumnal ) hypersensitivity natural environment Acute chronic clinically significant abnormality , determine medical history , physical examination clinical laboratory screening test , opinion investigator , might interfere study objective . Subjects physical examination finding clinical laboratory screening result would grade 2 high AE severity grade scale exclude entry study History leukemia blood disease solid organ cancer History thrombocytopenic purpura know bleed disorder History seizures Known suspect immunosuppressive immunodeficient condition kind , include HIV infection Known chronic HBV HCV infection Known tuberculosis infection evidence previous tuberculosis exposure History chronic alcohol abuse and/or illegal drug use Pregnancy lactation . Systemic connective tissue disorder Adrenal gland disease Hereditary , degenerative progredient diseases nervous system Any condition , opinion investigator , would increase health risk subject he/she participates study would interfere evaluation study objectives Allergic , include anaphylactic , reaction ( influenza ) vaccine</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>51 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>LAIV H5N2</keyword>
	<keyword>Influenza vaccine</keyword>
	<keyword>Russia</keyword>
</DOC>